Quality Systems – Page 294

Oot Dissolution Trend in multi-strength campaign: GMP investigation steps and batch disposition

Investigation Steps for Out-of-Test Dissolution Trends in Multi-Strength Campaigns In pharmaceutical manufacturing, particularly in solid oral dosage forms like tablets and capsules, maintaining product quality is an essential priority. A…

Capsule Shell Brittleness during compression: GMP investigation steps and batch disposition

Investigating Capsule Shell Brittleness during Compression: Key GMP Steps The issues surrounding capsule shell brittleness during compression can significantly impact batch quality and production efficiency in pharmaceutical manufacturing. As professionals…

Sticking And Picking after excipient change: sampling plan fixes to avoid repeat OOS

Addressing the Issues of Sticking and Picking Following an Excipient Change Sticking and picking of tablets during manufacturing processes can significantly impact product quality and batch release. These defects often…

Weak QMS Causing Repeat Deviations? QMS Design Solutions

Is Your Quality Management System Contributing to Repeat Deviations? Discover Solutions Weaknesses within a Quality Management System (QMS) can lead to repeated deviations in pharmaceutical manufacturing and quality control processes.…

GMP Non-Compliance Issues? Practical GMP System Solutions

Addressing GMP Non-Compliance Issues: Effective Solutions for Pharmaceutical Systems Non-compliance with Good Manufacturing Practices (GMP) can lead to significant challenges within pharmaceutical manufacturing and quality control systems. Common signals of…

QA Bottlenecks Slowing Release? Systems and Workflow Solutions

Addressing QA Bottlenecks Affecting Batch Release: Effective Systems and Workflow Solutions In the realm of pharmaceutical manufacturing, quality assurance (QA) plays a critical role in ensuring the integrity and safety…

Ineffective CAPA Systems? How to Measure and Improve Effectiveness

Improving CAPA Effectiveness in Pharmaceutical Quality Systems In a highly regulated environment like pharmaceuticals, the effectiveness of Corrective and Preventive Actions (CAPA) is pivotal for maintaining product quality and compliance.…

483s, Warning Letters, and Import Alerts? Inspection Readiness and Response Solutions

Inspection Readiness and Response Solutions for 483s, Warning Letters, and Import Alerts In the highly regulated pharmaceutical landscape, encountering regulatory inspections and enforcement actions can be a daunting experience for…

GMP Non-Compliance and Audit Findings? Quality System Solutions That Close the Gaps

Addressing GMP Non-Compliance Issues and Audit Findings with Quality System Solutions In pharmaceutical manufacturing, ensuring regulatory compliance and maintaining robust quality systems are critical to avoiding audit findings and non-compliance…

Repeat Deviations and CAPA Breakdowns? Real-World Case Studies and Prevention Solutions

Resolving Issues with Recurring Deviations and Improving CAPA Effectiveness Pharmaceutical manufacturing is complex, where deviations can disrupt processes, increase costs, and lead to non-compliance with regulatory standards. When faced with…

Managing Deviations in Batch Records for Enteric-Coated Tablets

Managing Deviations in Batch Records for Enteric-Coated Tablets Managing Deviations in Batch Records for Enteric-Coated Tablets Introduction: In the pharmaceutical industry, maintaining the integrity of batch records is crucial for…

Managing Documentation Deviations in Process Validation Protocols

Managing Documentation Deviations in Process Validation Protocols Managing Documentation Deviations in Process Validation Protocols Introduction: In the pharmaceutical industry, process validation is a critical component of ensuring product quality and…